Home › Vasculitis › NCT04919538

Longitudinal Study for Relapsing Polychondritis

Who can join

All ages · All sexes

Inclusion Criteria:

* 1\. Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.

Exclusion Criteria:

* 1\. Inability to provide consent, or in the case of minors, assent.

About the study

Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.

Sponsor: University of Pennsylvania · Participants: 100 · Started: Feb 26, 2021

Contact the study team

• Carol McAlear · Phone: 7813214567

Official record on ClinicalTrials.gov — NCT04919538

Locations in the U.S.

Conditions

• Vasculitis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.